Gene · 8081
Papers1,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Properties of Adenovirus Vectors with Increased Affinity to DSG2 and the Potential Benefits of Oncolytic Approaches and Gene Therapy. | Viruses | 2022 | 36016457 | PubTator, text mining | PubMed |
| Harnessing Human Papillomavirus' Natural Tropism to Target Tumors. | Viruses | 2022 | 36016277 | PubTator, text mining | PubMed |
| Current Vaccine Platforms in Enhancing T-Cell Response. | Vaccines (Basel) | 2022 | 36016254 | PubTator, text mining | PubMed |
| Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels. | Vaccines (Basel) | 2022 | 36016151 | PubTator, text mining | PubMed |
| Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models. | Int J Mol Sci | 2022 | 36012152 | PubTator, text mining | PubMed |
| Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36011030 | PubTator, text mining | PubMed |
| SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern. | Proc Natl Acad Sci U S A | 2022 | 35994646 | PubTator, text mining | PubMed |
| Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2. | Mol Ther | 2022 | 35949171 | PubTator, text mining | PubMed |
| Comparative characterization of antibody responses induced by Ad5-vectored spike proteins of emerging SARS-CoV-2 VOCs. | Signal Transduct Target Ther | 2022 | 35906201 | PubTator, text mining | PubMed |
| The Composites of Polyamide 12 and Metal Oxides with High Antimicrobial Activity. | Polymers (Basel) | 2022 | 35893987 | PubTator, text mining | PubMed |
| Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer. | Bioengineering (Basel) | 2022 | 35892755 | PubTator, text mining | PubMed |
| Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis. | Vaccines (Basel) | 2022 | 35891263 | PubTator, text mining | PubMed |
| Viral Vector Vaccine Development and Application during the COVID-19 Pandemic. | Microorganisms | 2022 | 35889169 | PubTator, text mining | PubMed |
| Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production. | Int J Mol Sci | 2022 | 35886882 | PubTator, text mining | PubMed |
| NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss. | Cells | 2022 | 35883667 | PubTator, text mining | PubMed |
| Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer's Disease Pathology, Constitute a Potential Object for Early Diagnosis. | Front Aging Neurosci | 2022 | 35847683 | PubTator, text mining | PubMed |
| Mucosal vaccine delivery: A focus on the breakthrough of specific barriers. | Acta Pharm Sin B | 2022 | 35818435 | PubTator, text mining | PubMed |
| Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses. | Front Mol Biosci | 2022 | 35813830 | PubTator, text mining | PubMed |
| ErbB3-Targeting Oncolytic Adenovirus Causes Potent Tumor Suppression by Induction of Apoptosis in Cancer Cells. | Int J Mol Sci | 2022 | 35806132 | PubTator, text mining | PubMed |
| Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer. | Oncoimmunology | 2022 | 35800156 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8081/papers?page=9